Skip to main content

Table 2 Multivariate analyses of predictors of poor functional outcomes

From: The association between serum adiponectin and 3-month outcome after ischemic stroke

  OR 95% CI P
Age (increase per unit) 1.06 1.01–1.12 0.012
Atrial fibrillation (yes vs. no) 1.39 0.97–1.76 0.13
Stroke severity, NIHSS (increase per unit) 1.08 1.03–1.14 < 0.001
Lesion volumes (increase per unit) 1.02 1.00–1.04 0.021
IV thrombolysis and/or mechanical thrombectomy (yes vs. no) 0.64 0.51–0.87 0.025
Stroke syndrome (TACS vs other) 1.62 0.65–3.87 0.49
Glucose (increase per unit) 1.19 1.05–1.30 0.015
CRP (increase per unit) 1.45 1.11–1.76 0.003
Adiponectin (increase per unit) 1.24 1.13–1.37 < 0.001
  1. Poor functional outcome was defined as an mRS > 2
  2. OR odd ratio, CI confidence interval, mRS modified Rankin Scale, NIHSS National Institutes of Health Stroke Scale, CRP C-reactive protein, TACS total anterior circulation syndrome
  3. Adjusted for significant factors which confirmed in Table 1, including age, atrial fibrillation, IV thrombolysis and/or mechanical thrombectomy, NIHSS at admission, lesion volumes, stroke syndrome, serum levels of glucose, CRP and adiponectin